Market Closed -
Other stock markets
|
After market 02:48:50 pm | |||
25.25 EUR | -1.14% | 25.07 | -0.71% |
04:54pm | UBS Upgrades Koninklijke Philips to Neutral From Sell | MT |
04:00pm | PHILIPS : Deutsche Bank upgrades recommendation to 'hold | CF |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's profit outlook over the next few years is a strong asset.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 36.69 times its estimated earnings per share for the ongoing year.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.75% | 24.75B | B | ||
+7.78% | 220B | B | ||
+6.17% | 183B | B- | ||
+10.47% | 133B | B- | ||
+24.25% | 107B | A- | ||
-0.95% | 63.05B | A- | ||
+11.11% | 51.74B | B+ | ||
+4.81% | 50.47B | B+ | ||
-0.99% | 40.91B | A | ||
+23.61% | 31.91B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PHIA Stock
- Ratings Philips NV